Taha Merghoub

51PUBLICATIONS
423CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (51)

|Jun 26, 2026
Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models.

|Jun 22, 2026
Immune checkpoint blockade augments lymphodepleting chemotherapy-induced antitumor immunity by expanding effector CD8+ T cell clones.

|Apr 03, 2026
Mutant p53 Directs PARP to Regulate Replication Stress and Drive Breast Cancer Metastasis.

Gu Xiao, George K Annor, Katherine W Harmon

|Jan 07, 2026
IL10R Inhibition Induces Neutrophil Tumoricidal Activity.

Danny N Khalil, Ricardo Gomez, Amit Regev

|Nov 17, 2025
Thrombospondin-1-CD47 signaling contributes to the development of T cell exhaustion in cancer.

Chien-Huan Weng, Anais Assouvie, Lauren Dong

|Jul 25, 2025
First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors.

Omid Hamid, Dana B Cardin, F Stephen Hodi

Pageof 9

Frequent Collaborators

30 joint publications

Jedd Wolchok

9 joint publications

Roberta Zappasodi

8 joint publications

Benjamin Greenbaum

8 joint publications

Sadna Budhu